Displaying 781 - 800 of 1590
FTC Chairwoman Releases 2013 Annual Highlights
Date
Federal Trade Commission Chairwoman Edith Ramirez released the agency’s 2013 Annual Highlights today at the Spring Meeting of the American Bar Association’s Section of Antirust Law in Washington...
Endo Health Solutions Inc., Boca Life Science Holdings, LLC, and Boca Pharmacal, LLC, In the Matter of
Pharmaceutical companies Endo Health Sciences Inc. (Endo) and Boca Life Science Holdings, LLC and Boca Pharmacal, LLC (Boca) agreed to a settlement resolving FTC charges that Endo’s acquisition of Boca would be anticompetitive. Under the settlement, the companies will relinquish their rights to market and distribute four generic multivitamin fluoride drops for children, and will sell three other generic drugs in development.The proposed settlement preserves competition in the pharmaceutical markets for four prescription generic multivitamin drop products given to children in the United States who do not have access to fluoridated water. In addition, the FTC’s settlement preserves future competition for three generic drugs where the proposed acquisition would eliminate one likely future entrant from a very limited pool of future entrants.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
131 0225
Docket Number
C-4430
Mar20
Examining Health Care Competition
-
The Federal Trade Commission held a public workshop to study certain activities and trends that may affect competition in the evolving health care industry. The workshop explored current developments...
FTC Announces Agenda for March 20-21 Workshop Examining U.S. Health Care Competition Issues
Date
The Federal Trade Commission has announced the agenda for the upcoming public workshop on “Examining U.S. Health Care Competition.” The workshop will be held in the FTC Conference Center at 601 New...
FTC Staff Comment To Centers For Medicare and Medicaid Services Regarding "CY2015 Policy and Technical Changes to the Medicare Advantage and Prescription Drug Benefit Programs"
Date
Matter Number
V140006
Staff submitted a comment to CMS, in response to a request for public comments, regarding proposed changes in contracting for Medicare Part D. The comment recommended that CMS reconsider a proposal to...
FTC Staff Opinion: Rx Program Operated for the Benefit of Non-Profit Schools, Colleges, and Universities Appears to Fall within the NPIA Exemption to Robinson-Patman
Date
In a letter issued today, the staff of the Federal Trade Commission advised Quest Analytics Group that its proposal to operate a GPO-based prescription drug program for the benefit of a group of non...
FTC Staff Paper: State Legislators Should Carefully Evaluate Proposals to Limit Advanced Practice Registered Nurses’ Scope of Practice
Date
Federal Trade Commission staff has issued a policy paper suggesting that state legislators should be cautious when evaluating proposals to limit the scope of practice of Advanced Practice Registered...
FTC Approves Final Consent Settling Charges that Accretive Health Failed to Adequately Protect Consumers’ Personal Information
Date
Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that a company providing medical billing and revenue management services to...
Feb04
Follow-On Biologics Workshop: Impact of Recent Legislative and Regulatory Naming Proposals on Competition
-
The Federal Trade Commission held a workshop to explore competition issues involving biologic medicines and follow-on biologics. As described in the Federal Register Notice, the workshop focused on a...
Provider of Medical Transcript Services Settles FTC Charges That It Failed to Adequately Protect Consumers’ Personal Information
Date
A company that provides medical transcription services has agreed to settle Federal Trade Commission charges that its inadequate data security measures unfairly exposed the personal information of...
FTC Puts Conditions on Thermo Fisher Scientific Inc.’s Proposed Acquisition of Life Technologies Corporation
Date
Thermo Fisher Scientific Inc. (Thermo Fisher), a leading manufacturer of products used in scientific research, has agreed to sell assets to GE Healthcare to settle Federal Trade Commission charges...
FTC Puts Conditions on Endo Health Solutions’ Acquisition of Boca Life Science Holdings
Date
Pharmaceutical companies Endo Health Solutions Inc. (Endo) and Boca Life Science Holdings, LLC and Boca Pharmacal, LLC (Boca) have agreed to a settlement resolving Federal Trade Commission charges...
Statement of FTC Chairwoman Edith Ramirez on the U.S. District Court in the District of Idaho Ruling in the Matter of the Federal Trade Commission and the State of Idaho v. St. Luke’s Health System Ltd. and Saltzer Medical Group, P.A.
Date
Following the favorable court decision issued today, Federal Trade Commission Chairwoman Edith Ramirez said: “The district court’s ruling is an important victory that will benefit both competition and...
FTC Staff: Massachusetts Should Consider Removing Physician Supervision Requirements for Nurse Practitioners and Nurse Anesthetists
Date
Federal Trade Commission staff, in response to a request from Massachusetts State Representative Kay Khan, provided comments on Massachusetts House Bill 2009, stating that, as proposed, the...
Displaying 781 - 800 of 1590